Is DBMBF or MRK a better dividend investment in 2026?

DBMBF currently yields 5.71% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: DBMBF offers higher current income.

What is the dividend yield difference between DBMBF and MRK?

DBMBF has a forward dividend yield of 5.71% ($0.13/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 2.46 percentage points.

Home › Compare › DBMBF vs MRK

DBMBF vs MRK: Dividend Comparison 2026

DBMBF yields 5.71% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DBMBF wins by $13251.95M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DBMBF

● Live price

5.71%

Share price

$2.31

Annual div

$0.13

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$13251.98M

Annual income

$12,820,980,793.89

Full DBMBF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — DBMBF vs MRK

📍 DBMBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DBMBF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DBMBF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DBMBF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DBMBF

Annual income on $10K today (after 15% tax)

$485.74/yr

After 10yr DRIP, annual income (after tax)

$10,897,833,674.81/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, DBMBF beats the other by $10,897,832,867.06/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DBMBF + MRK for your $10,000?

DBMBF: 50%MRK: 50%

100% MRK50/50100% DBMBF

Portfolio after 10yr

$6626.01M

Annual income

$6,410,490,872.10/yr

Blended yield

96.75%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DBMBF

Analyst Ratings

Buy

Consensus: Buy

Price Target

$2.62

+13.3% upside vs current

Range: $2.62 — $2.62

Altman Z

1.5

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DBMBF buys

MRK buys

No recent congressional trades found for DBMBF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDBMBFMRK

Forward yield	5.71% ✓	3.25%
Annual dividend / share	$0.13	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	100% ✓	8.2%
Portfolio after 10y	$13251.98M ✓	$30.7K
Annual income after 10y	$12,820,980,793.89 ✓	$950.29
Total dividends collected	$13222.02M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy
Analyst price target	$2.62	$128.54 ✓

Year-by-year: DBMBF vs MRK ($10,000, DRIP)

Year	DBMBF Portfolio	DBMBF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$11,843	$1,142.91	$11,192	$351.54	+$651.00 → DBMBF
2	$15,202	$2,529.97	$12,524	$392.70	+$2.7K → DBMBF
3	$22,336	$6,070.16	$14,015	$438.65	+$8.3K → DBMBF
4	$40,571	$16,670.87	$15,682	$489.96	+$24.9K → DBMBF
5	$100,009	$56,598.74	$17,547	$547.23	+$82.5K → DBMBF
6	$367,795	$260,784.64	$19,632	$611.16	+$348.2K → DBMBF
7	$2,186,181	$1,792,640.99	$21,963	$682.53	+$2.16M → DBMBF
8	$22,256,052	$19,916,838.55	$24,571	$762.18	+$22.23M → DBMBF
9	$402,804,726	$378,990,749.47	$27,486	$851.08	+$402.78M → DBMBF
10	$13,251,981,850	$12,820,980,793.89	$30,745	$950.29	+$13251.95M → DBMBF

DBMBF vs MRK: Complete Analysis 2026

DBMBF — Stock

FIBRA Macquarie México (FIBRA Macquarie) (BMV:FIBRAMQ) is a real estate investment trust (fideicomiso de inversión en bienes raíces), or FIBRA, listed on the Mexican Stock Exchange (Bolsa Mexicana de Valores) targeting industrial, retail and office real estate opportunities in Mexico, with a primary focus on stabilized income-producing properties. FIBRA Macquarie's portfolio consists of 236 industrial properties and 17 retail properties, located in 20 cities across 16 Mexican states as of December 31, 2020. Nine of the retail properties are held through a 50/50 joint venture.

Full DBMBF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this DBMBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DBMBF vs SCHD DBMBF vs JEPI DBMBF vs O DBMBF vs KO DBMBF vs MAIN DBMBF vs JNJ DBMBF vs ABBV DBMBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.